Lycia Therapeutics Stock
HealthTechLooking to sell Lycia Therapeutics stock or options?
Lycia Therapeutics is a biotechnology firm focused on discovering and developing innovative therapeutics. Utilizing its lysosomal targeting chimeras platform, the company aims to create treatments that degrade extracellular and membrane-bound proteins responsible for various challenging diseases, such as cancers and autoimmune disorders. This approach assists medical professionals in accessing drugs designed to treat and potentially cure these conditions.
Blue Owl Capital, Versant Ventures, Franklin Templeton, Janus Henderson Investors, The Invus Group, Redmile Group, Marshall Wace, RTW Investments, Cowen Healthcare Investments, Venrock, Alexandria Venture Investments, Eli Lilly and Company.